Page last updated: 2024-09-03

pramipexole and Degenerative Diseases, Central Nervous System

pramipexole has been researched along with Degenerative Diseases, Central Nervous System in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Gencler, OS; Oztekin, MF; Oztekin, N	1
Eijkemans, MJC; Ferguson, TA; Liu, D; Nikolakopoulos, S; van den Berg, LH; van Eijk, RPA	1
Kalaria, DR; Kalia, YN; Merino, V; Patel, P; Patravale, VB	1
Coburn, KL; Doonan, SM; Lauterbach, EC; Mendez, MF; Shillcutt, SD; Victoroff, J	1
Abramova, NA; Bennett, JP; Cassarino, DS; Khan, SM; Painter, TW	1

Reviews

2 review(s) available for pramipexole and Degenerative Diseases, Central Nervous System

Article	Year
Increasing the efficiency of clinical trials in neurodegenerative disorders using group sequential trial designs. Journal of clinical epidemiology, 2018, Volume: 98 Topics: Amyotrophic Lateral Sclerosis; Central Nervous System Agents; Confidence Intervals; Early Termination of Clinical Trials; Equivalence Trials as Topic; Humans; Medical Futility; Neurodegenerative Diseases; Placebos; Pramipexole; Randomized Controlled Trials as Topic; Research Design; Time Factors	2018
Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data. The Journal of neuropsychiatry and clinical neurosciences, 2010,Winter, Volume: 22, Issue:1 Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Brain; Clonazepam; Desipramine; Dibenzothiazepines; Dopamine Agonists; Humans; Lithium Carbonate; Maprotiline; Melatonin; Neurodegenerative Diseases; Neuroprotective Agents; Olanzapine; Parkinson Disease; Pramipexole; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Valproic Acid	2010

Article

Year

Increasing the efficiency of clinical trials in neurodegenerative disorders using group sequential trial designs.

Journal of clinical epidemiology, 2018, Volume: 98

Topics: Amyotrophic Lateral Sclerosis; Central Nervous System Agents; Confidence Intervals; Early Termination of Clinical Trials; Equivalence Trials as Topic; Humans; Medical Futility; Neurodegenerative Diseases; Placebos; Pramipexole; Randomized Controlled Trials as Topic; Research Design; Time Factors

2018

Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data.

The Journal of neuropsychiatry and clinical neurosciences, 2010,Winter, Volume: 22, Issue:1

Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Brain; Clonazepam; Desipramine; Dibenzothiazepines; Dopamine Agonists; Humans; Lithium Carbonate; Maprotiline; Melatonin; Neurodegenerative Diseases; Neuroprotective Agents; Olanzapine; Parkinson Disease; Pramipexole; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Valproic Acid

2010

Trials

1 trial(s) available for pramipexole and Degenerative Diseases, Central Nervous System

Article	Year
Comparison of pramipexole versus ropinirole in the treatment of Parkinson's disease. Ideggyogyaszati szemle, 2022, 01-30, Volume: 75, Issue:1-02 Topics: Adult; Aged; Aged, 80 and over; Humans; Indoles; Middle Aged; Neurodegenerative Diseases; Parkinson Disease; Pramipexole	2022

Other Studies

2 other study(ies) available for pramipexole and Degenerative Diseases, Central Nervous System

Article	Year
Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2014, Volume: 88, Issue:1 Topics: Administration, Cutaneous; Animals; Antioxidants; Benzothiazoles; Chromatography, High Pressure Liquid; Ear, External; Electrochemistry; Electroosmosis; Gels; Humans; Iontophoresis; Kinetics; Male; Neurodegenerative Diseases; Parkinson Disease; Pramipexole; Rats; Rats, Wistar; Skin; Sulfites; Swine	2014
Inhibition by R(+) or S(-) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH-SY5Y neuroblastoma. Journal of neuroscience research, 2002, Feb-15, Volume: 67, Issue:4 Topics: 1-Methyl-4-phenylpyridinium; Alzheimer Disease; Amyloid beta-Peptides; Anti-Bacterial Agents; Aristolochic Acids; Benzothiazoles; Bongkrekic Acid; Brain; Caspase Inhibitors; Caspases; Cell Death; Dose-Response Relationship, Drug; Enzyme Inhibitors; Free Radical Scavengers; Humans; Neuroblastoma; Neurodegenerative Diseases; Neurons; Parkinson Disease; Peptide Fragments; Phenanthrenes; Pramipexole; Thiazoles; Tumor Cells, Cultured	2002

Article

Year

Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2014, Volume: 88, Issue:1

Topics: Administration, Cutaneous; Animals; Antioxidants; Benzothiazoles; Chromatography, High Pressure Liquid; Ear, External; Electrochemistry; Electroosmosis; Gels; Humans; Iontophoresis; Kinetics; Male; Neurodegenerative Diseases; Parkinson Disease; Pramipexole; Rats; Rats, Wistar; Skin; Sulfites; Swine

2014

Inhibition by R(+) or S(-) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH-SY5Y neuroblastoma.

Journal of neuroscience research, 2002, Feb-15, Volume: 67, Issue:4

Topics: 1-Methyl-4-phenylpyridinium; Alzheimer Disease; Amyloid beta-Peptides; Anti-Bacterial Agents; Aristolochic Acids; Benzothiazoles; Bongkrekic Acid; Brain; Caspase Inhibitors; Caspases; Cell Death; Dose-Response Relationship, Drug; Enzyme Inhibitors; Free Radical Scavengers; Humans; Neuroblastoma; Neurodegenerative Diseases; Neurons; Parkinson Disease; Peptide Fragments; Phenanthrenes; Pramipexole; Thiazoles; Tumor Cells, Cultured

2002